Cytokine Profile and Prognostic Significance of High Neutrophil-lymphocyte Ratio in Colorectal Cancer
Overview
Authors
Affiliations
Background: High circulating neutrophil-lymphocyte ratio (NLR) appears to be prognostic in metastatic colorectal cancer (mCRC). We investigated the relationship of NLR with circulating cytokines and molecular alterations.
Methods: We performed retrospective analyses on multiple cohorts of CRC patients (metastatic untreated (n=166), refractory metastatic (n=161), hepatectomy (n=198), stage 2/3 (n=274), and molecularly screened (n=342)). High NLR (ratio of absolute neutrophil-to-lymphocyte counts in peripheral blood) was defined as NLR>5. Plasma cytokines were evaluated using multiplex-bead assays. Kaplan-Meier estimates, non-parametric correlation analysis, and hierarchical cluster analyses were used.
Results: High NLR was associated with poor prognosis in mCRC (hazard ratio (HR) 1.73; 95% confidence interval (CI):1.03-2.89; P=0.039) independent of known prognostic factors and molecular alterations (KRAS/NRAS/BRAF/PIK3CA/CIMP). High NLR correlated with increased expression of interleukin 6 (IL-6), IL-8, IL-2Rα, hepatocyte growth factor, macrophage-colony stimulating factor, and vascular epidermal growth factor in exploratory (n=39) and validation (n=166) cohorts. Fourteen additional cytokines correlated with high NLR in the validation cohort. All 20 cytokines fell into three major clusters: inflammatory cytokines, angiogenic cytokines, and epidermal growth factor ligands. In mCRC, composite stratification based on NLR-cytokine score provided enhanced prognostic information (HR 2.09; 95% CI: 1.59-2.76; P<0.001) over and above NLR.
Conclusions: High NLR is an independent poor prognostic marker in CRC and correlates with a distinct cytokine profile related to key biological processes involved in carcinogenesis. A composite NLR-cytokine stratification has enhanced prognostic value in mCRC.
Chiu T, Liu T, Chang C, Hu W Int J Colorectal Dis. 2025; 40(1):55.
PMID: 40009243 PMC: 11865130. DOI: 10.1007/s00384-025-04839-4.
Wu Z, Jiang Y, Gong H, Jiang T, Su A, Yi L Gland Surg. 2025; 14(1):13-27.
PMID: 39958900 PMC: 11826260. DOI: 10.21037/gs-24-397.
Hodgkin lymphoma and liquid biopsy: a story to be told.
Velasco-Suelto J, Galvez-Carvajal L, Comino-Mendez I, Rueda-Dominguez A J Exp Clin Cancer Res. 2024; 43(1):184.
PMID: 38956619 PMC: 11218217. DOI: 10.1186/s13046-024-03108-6.
Ding Y, Liu Z, Li J, Niu W, Li C, Yu B BMC Surg. 2024; 24(1):89.
PMID: 38481180 PMC: 10935841. DOI: 10.1186/s12893-024-02384-5.
Wang Q, Zhong W, Shen X, Hao Z, Wan M, Yang X NPJ Precis Oncol. 2024; 8(1):61.
PMID: 38431733 PMC: 10908779. DOI: 10.1038/s41698-024-00533-w.